Improvement in bleeding time and bleeding condition in cancer patients

Statistically significant improvements seen in FAS-treated group compared to the control group. These are severely thrombocytopenic patients. The data obtained in China used the lyophilized formulation. We will use the ready-to-use formulation for clinical trials in similar patients in the USA.